EW(Edwards Lifesciences Corporation) · 财务报表

EW(Edwards Lifesciences Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$5.23B$4.46B$5.01B$5.44B$6.07B
毛利润$3.98B$3.74B$4.03B$4.32B$4.73B
营业利润$1.69B$1.50B$1.31B$1.38B$1.26B
净利润$1.50B$1.52B$1.40B$4.17B$1.07B
经营现金流$1.73B$1.22B$895.80M$542.30M$1.60B
自由现金流$1.41B$973.60M$642.80M$289.90M$1.33B
摊薄每股收益$2.38$2.44$2.30$6.97$1.83

Edwards Lifesciences Corporation EW